Dendreon SEATTLE, WA (KPLU) - A Seattle biotech company, Dendreon, is developing a treatment for late-stage prostate cancer. It's hoping to produce the first cancer vaccine to receive FDA approval. KPLU's Dave Meyer looks at the company with financial commentator Greg Heberlein. © Copyright 2009, KPLU